SEC Form 4 · accession 0001461755-16-000075
Atlantic Capital Bancshares, Inc. · ACBI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Douglas Lloyd Williams
Officer — Chief Executive Officer · Director
Period of report
Apr 5, 2016
Accepted (ET)
Apr 7, 2016 · 5:07 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001461755
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Apr 5, 2016 | M | 2,354 | $10.00 | A | 153,005 | D | |
| Common StockF2 | Apr 5, 2016 | S | 2,354 | $13.7104 | D | 150,651 | D | |
| Common Stock | Apr 6, 2016 | M | 1,455 | $10.00 | A | 152,106 | D | |
| Common StockF3 | Apr 6, 2016 | S | 1,455 | $13.7561 | D | 150,651 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F4 | $10.00 | Apr 5, 2016 | M | 2,354 | D | May 14, 2007 | May 14, 2017 | Common Stock | 2,354 | 97,646 | D |
| Stock Option (Right to Buy)F4 | $10.00 | Apr 6, 2016 | M | 1,455 | D | May 14, 2007 | May 14, 2017 | Common Stock | 1,455 | 96,191 | D |
Explanation of responses
- F1The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 4, 2015.
- F2The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $13.63 to $13.81, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F3The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $13.20 to $13.88, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F4The option became fully vested three years after the date of grant listed.